ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GD vs TMO // EV/EBITDA & P/E VALUATION

General Dynamics Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GD 10 — TMO 3
▲ EV/EBITDA & P/E VALUATION LEADER: GD
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GD VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GD TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 14.00% 9.30% +4.70 GD /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 16.6x 30.4x -13.80 GD /valuation <GO>
Free Cash Flow Yield 3.95% 2.40% +1.55 GD /fcf-yield <GO>
Operating Margin 10.20% 17.40% -7.20 TMO /operating-margins <GO>
Net Profit Margin 8.00% 15.10% -7.10 TMO /net-margins <GO>
Revenue Growth (YoY) 10.10% 3.90% +6.20 GD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 1.59% 0.24% +1.35 GD /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.65 4.50 +0.15 GD /balance-sheet <GO>
Piotroski F-Score Quality 9/9 8/9 +1.00 GD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 70.9 62.9 +8.00 GD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.99 0.94 +0.05 GD /macro-sensitivity <GO>
Forward P/E Multiple 22.1x 36.3x -14.20 GD /forward-pe <GO>
Enterprise Scale & Market Cap $100.33B $262.22B -$161.89B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GD REV TMO REV GD GROSS % TMO GROSS % GD FCF TMO FCF
FY 2025 $52.55B $44.56B — — $3.96B $6.29B
FY 2024 $47.72B $42.88B — — $3.20B $7.27B
FY 2023 $42.27B $42.86B — — $2.81B $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GD // BETA 0.99
TMO // BETA 0.94